Avenue Therapeutics, Inc.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in…
Biotechnology
US, New York [HQ]
Lobbying Analysis
Lobbying · US Senate · Influence
Avenue Therapeutics, Inc. has no lobbying expenses in our database.
History
DownloadFY | Quarter | Expense For Lobby Disclosure | LDA Reference |
---|---|---|---|
No data |